Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy.
Cheng Y, Cheng H, Jiang C, Qiu X, Wang K, Huan W, Yuan A, Wu J, Hu Y. · 2015
Read Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. by Cheng Y, Cheng H, Jiang C, Qiu X, Wang K, Huan W, Yuan A, Wu J, Hu Y. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4659941.txt.
Description
Yong Cheng and colleagues brought out a 2015 study boosting photodynamic therapy by loading its drug into oxygen-carrying nanodroplets. Photodynamic therapy uses light to turn tumour oxygen into a cell-killing form, but tumours are often oxygen-poor, and treatment itself uses oxygen up. Their droplets use perfluorocarbon, which holds much oxygen. The work appeared in Nature Communications.
The loaded drug generated the killing oxygen form faster and killed more cancer cells in dishes. Injected into mouse tumours, the treatment slowed growth. A single intravenous dose also significantly slowed tumour growth, where standard photodynamic therapy had no effect. The authors propose this oxygen self-enriching design as a way to strengthen existing clinical photodynamic treatments and future ones alike.
Catalog record
| CREATOR | Cheng Y, Cheng H, Jiang C, Qiu X, Wang K, Huan W, Yuan A, Wu J, Hu Y. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |